Brussels, 14 May 2026 — The European Commission adopted Regulation (EU) 2026/921 on 14 May 2026, amending Annex XVII of the REACH Regulation to restrict two biocidal substances — triclosan and novel copper-based nanodispersions — in antifouling paints for ships. Effective 1 June 2026, all such coatings placed on the EU market must be supported by valid active substance authorisation under the EU Biocidal Products Regulation (BPR), or a formally recognised exemption. The move directly affects over 230 Chinese exporters of marine corrosion protection coatings, particularly those supplying high-performance systems for LNG carrier cargo tanks and underwater hull zones of luxury cruise vessels.

Event Overview

The European Commission published Regulation (EU) 2026/921 in the Official Journal of the European Union on 14 May 2026. It adds triclosan (a TBT alternative historically used in slow-release antifouling systems) and newly commercialised copper-based nanodispersions to entry 77 of REACH Annex XVII. The restriction prohibits placing on the market or using these substances in biocidal products intended for ship hull antifouling coatings. From 1 June 2026, importers and downstream users placing coated components or finished coating products into the EU must hold ECHA-issued BPR active substance authorisation (or an accepted equivalent status), verified at EU port entry. Non-compliant consignments face refusal of entry and potential customs-led retrospective enforcement, including financial penalties and product recall obligations.

Impact on Specific Industry Segments

Direct Trade Enterprises: Exporters of finished marine coatings — especially those with annual EU shipments exceeding €2 million — are now required to manage dual compliance: REACH registration (for substances) and BPR authorisation (for biocidal function). Impact manifests in delayed customs clearance, increased pre-shipment documentation burden (e.g., certified BPR dossiers, formulation declarations), and elevated risk of port detention where proof of authorisation is incomplete or misaligned with actual product composition.

Raw Material Suppliers: Chinese manufacturers supplying triclosan or copper nanodispersions to coating formulators must now verify whether their customers’ end-use falls under the BPR scope. If so, they may be drawn into the supply chain due diligence process as ‘substance suppliers’ under Article 95 of the BPR. This requires proactive engagement with EU-based representatives and submission of data packages to ECHA — a shift from previous practice where raw material compliance was largely assumed at the formulation level.

Coating Formulators & Manufacturers: Firms producing antifouling coatings for export must revise formulations prior to 1 June 2026, validate alternatives through performance testing (e.g., fouling resistance, leaching rate, adhesion under immersion), and initiate new BPR authorisation dossiers — either individually or via a substance group consortium. Crucially, reformulation alone does not suffice; regulatory approval of the *active substance* — not just the final product — is mandatory. This introduces multi-year timelines and costs exceeding €500,000 per active substance dossier.

Supply Chain Service Providers: Third-party regulatory consultancies, testing laboratories, and EU Authorised Representatives (ARs) report surging demand for BPR dossier support, analytical method validation (e.g., ICP-MS for copper speciation), and customs classification advisory. However, capacity constraints exist: fewer than 12 EU-based ARs currently hold verified expertise in marine biocidal product dossiers, creating bottlenecks in dossier submission readiness.

Key Focus Areas and Recommended Actions

Verify current product status against BPR Article 95 List

Companies must cross-check whether triclosan or their specific copper nanodispersion variant appears on the ECHA Article 95 list of approved active substances. Absence indicates no valid authorisation exists — meaning immediate reformulation or sourcing of pre-authorised alternatives is required. Relying on generic ‘copper compound’ claims is insufficient; nanoscale dispersion characteristics trigger distinct evaluation criteria.

Engage an EU Authorised Representative before 1 April 2026

Non-EU applicants cannot submit BPR dossiers directly. Appointment of an EU-based AR is mandatory for dossier submission and ongoing compliance management. Late appointments risk missing ECHA’s 2026 Q2 validation window, delaying dossier acceptance and jeopardising June 2026 market access.

Update technical documentation for customs and port authorities

Exporters must prepare substantiated declarations — signed by technical directors — confirming absence of restricted substances *and* providing evidence of BPR authorisation (e.g., dossier reference number, AR contact, validity period). Blanket statements or self-declarations without traceable ECHA references will not satisfy EU port control officers.

Editorial Perspective / Industry Observation

Analysis shows this amendment marks a structural shift: the EU is no longer regulating biocidal function solely through the BPR product authorisation pathway, but increasingly leveraging REACH’s restriction mechanism to enforce upstream substance-level control — even for complex, nano-formulated actives. Observably, the inclusion of copper nanodispersions reflects growing regulatory attention on particle-specific toxicity and environmental persistence, rather than bulk metal thresholds. From an industry perspective, this signals that ‘functionally equivalent’ replacements — without full BPR authorisation — carry higher compliance risk than previously assumed. Current more critical concern is not just substitution speed, but whether alternative actives (e.g., zinc pyrithione variants or enzyme-based systems) can meet both performance benchmarks *and* the evolving evidentiary bar for environmental safety under BPR Review Programme 2.

Conclusion

This REACH amendment underscores how environmental regulation is converging with trade policy at the functional-material interface. For China’s marine coatings sector, it represents less a one-off compliance hurdle and more a catalyst for systemic upgrading: from reactive formulation adjustment toward integrated regulatory intelligence, lifecycle toxicology planning, and collaborative substance stewardship. A rational conclusion is that competitiveness post-2026 will hinge less on cost or coverage performance alone, and more on demonstrable, auditable regulatory foresight across the entire value chain.

Source Attribution

Primary source: Commission Regulation (EU) 2026/921, published in Official Journal of the European Union, L 142/1, 14 May 2026. Further details available via ECHA’s Annex XVII database (echa.europa.eu/annex-xvii) and BPR Article 95 List (echa.europa.eu/article-95-list). Ongoing monitoring is advised for ECHA’s upcoming 2026 Q3 guidance on nanomaterial-specific data requirements for biocidal actives — expected to clarify analytical validation expectations for copper nanodispersions.